Arixtra 7.5mg Injection

Welcome to the information page for Arixtra 7.5mg Injection, brought to you by Glaxo SmithKline Pharmaceuticals Ltd. This product contains the active ingredient Fondaparinux (7.5mg) and is indicated for Deep vein thrombosis,Pulmonary embolism. Here, you can find crucial details, including its uses, pricing, and options to add it to your wishlist or compare it with similar medications.

MRP: ₹ 1320
Packing: 0.6 ml in 1 vial
Salt Combination: Fondaparinux (7.5mg)
Brand: Glaxo SmithKline Pharmaceuticals Ltd
Uses: Deep vein thrombosis,Pulmonary embolism

Description

Arixtra 7.5mg Injection is an anticoagulant medicine used in the treatment of deep vein thrombosis (clot in veins of leg) and pulmonary embolism (clot in artery of lungs)
It helps to prevent formation of harmful blood clots in blood vessels
Arixtra 7.5mg Injection also reduces the risk of getting clots in people who have undergone knee or hip replacement surgeries, or who have been bedridden for long
It is administered under the supervision of a doctor
Your doctor will decide the dose and duration of the medicine for you
You should continue all your other medicines that are advised by the doctor for your long-term treatment even after this injection.
Use of this medicine may increase your risk of bleeding
Let your doctor know immediately if you see pinpoint rash or blood in your vomits, urine, or stool
Before taking it, you must inform the doctor if you are suffering from any bleeding disorder, kidney or liver disease
Also, let your doctor know if you are pregnant or breastfeeding and about all the other medications that you are taking regularly.

Cautions

Liver:	CAUTION: Arixtra 7.5mg Injection should be used with caution in patients with severe liver disease. Dose adjustment of Arixtra 7.5mg Injection may be needed. Please consult your doctor.
Kidney:	CAUTION: Arixtra 7.5mg Injection should be used with caution in patients with kidney disease. Dose adjustment of Arixtra 7.5mg Injection may be needed. Please consult your doctor.^Use of Arixtra 7.5mg Injection is not recommended in patients with severe kidney disease.
Driving:	CONSULT YOUR DOCTOR: It is not known whether Arixtra 7.5mg Injection alters the ability to drive. Do not drive if you experience any symptoms that affect your ability to concentrate and react.
Breast feeding:	SAFE IF PRESCRIBED: Arixtra 7.5mg Injection is probably safe to use during breastfeeding. Limited human data suggests that the drug does not represent any significant risk to the baby.
Pregnency:	SAFE IF PRESCRIBED: Arixtra 7.5mg Injection is generally considered safe to use during pregnancy. Animal studies have shown low or no adverse effects to the developing baby; however, there are limited human studies.
Alcohol:	UNSAFE: It is unsafe to consume alcohol with Arixtra 7.5mg Injection.
Drug Action:	Selective Factor Xa Inhibitors
Therapeutic class:	CARDIAC
Habit Forming:	No
Chemical Class:	Synthetic Glucopyranoside

Uses of Arixtra 7.5mg Injection

Deep vein thrombosis Pulmonary embolism

Missed Doses

If you miss a dose of Arixtra 7.5mg Injection, take it as soon as possible. However, if it is almost time for your next dose, skip the missed dose and go back to your regular schedule. Do not double the dose.

FAQs

Frequestly asked Questions

Can the use of Arixtra 7.5mg Injection increase the risk of bleeding?

Yes, Arixtra 7.5mg Injection increases the risk of bleeding, and the affects of Arixtra 7.5mg Injection may last for 4 days even after stopping this medicine. Always be careful while doing activities that may cause an injury or bleeding. Tell your doctor immediately if you notice any abnormal bruising or bleeding.

Side Effects